Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change
14/09/26	€0.6400	0.00%
11/09/26	€0.6400	0.00%
10/09/26	€0.6400	0.00%
09/09/26	€0.6400	0.00%
08/09/26	€0.6400	0.00%

Real-time Euronext Paris

More quotes

Market Closed - Euronext Paris 23:55:00 14/09/2026 HKT			5-day change	1st Jan Change
0.6400 ^EUR	0.00%		0.00%	-63.43%

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 147K 120K 109K 205K 14.1M 206K 1.44M 554K 7.16M 553K 541K 22.75M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.28M 12.49M 11.33M 21.26M 1.46B 21.42M 149M 57.5M 743M 57.39M 56.12M 2.36B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALSAF	Real-time
Deutsche Boerse AG	OR9	Delayed
Börse Stuttgart	OR9	Delayed

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-29	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-29	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
12-01	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/07/25	Alert wrongly tagged to Safe SA withdrawn	RE
28/12/24	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/09/24	The market burns its idols
06/02/24	Safe: wins its appeal against Neo Medical
28/12/23	Safe: audit initiated for a turnaround plan

Safe S.A. Stock

Stocks

ALSAF

FR001400ZU25

Medical Equipment, Supplies & Distribution

Valuation: Safe S.A.

Chart: Safe S.A.

Latest news: Safe S.A.

Press Releases: Safe S.A.

News in other languages: Safe S.A.

Quotes and Performance

Price Extremes

Managers and Directors: Safe S.A.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/09/24	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
25/11/23	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

09-09	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
08-26	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
06-30	Safe Group améliore nettement ses résultats annuels
05-29	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-29	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

1 week	0.64	0.64
1 month	0.64	0.64
Current year	0.54	1.81
1 year	0.54	2.6
3 years	0.54	141,014.1
5 years	0.54	6,204,899,937.95
10 years	0.54	10,000,000,000

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE S.A.	0.00%	0.00%	-73.33%	-100.00%	148K
STRYKER CORPORATION	+2.29%	+1.97%	-25.26%	-4.45%	106B
SMITH & NEPHEW PLC	+3.97%	-1.46%	-25.37%	-1.83%	11.47B
GLAUKOS CORPORATION	+2.30%	-7.54%	+112.17%	+126.79%	9.86B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.89%	-5.41%	-54.63%	-71.38%	3.94B
DOUBLE MEDICAL TECHNOLOGY INC.	+1.42%	-4.78%	-29.22%	+26.45%	2.33B
INSPIRE MEDICAL SYSTEMS, INC.	+1.81%	+19.60%	-7.95%	-65.55%	2.11B
INSIGHT LIFETECH CO., LTD.	-0.20%	-5.31%	-	-	1.84B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+0.18%	-4.35%	-23.37%	-31.04%	1.5B
Average	+1.48%	-2.50%	-15.87%	-15.13%	15.42B
Weighted average by Cap.	+2.89%	-7.85%	-15.99%	+2.59%

	2024	2025
Net sales	5.04M 5.82M 4.76M 4.32M 8.1M 558M 8.15M 56.82M 21.89M 283M 21.85M 21.37M 899M	5.36M 6.19M 5.06M 4.59M 8.61M 593M 8.68M 60.46M 23.3M 301M 23.25M 22.74M 957M
Net income	-1.93B -2.23B -1.82B -1.65B -3.1B -213B -3.12B -21.74B -8.38B -108B -8.36B -8.18B -344B	-4.67M -5.39M -4.41M -4M -7.51M -517M -7.56M -52.68M -20.3M -262M -20.26M -19.81M -834M
Net Debt	11.47M 13.24M 10.83M 9.82M 18.42M 1.27B 18.56M 129M 49.82M 644M 49.72M 48.63M 2.05B	13.11M 15.13M 12.37M 11.23M 21.06M 1.45B 21.21M 148M 56.95M 736M 56.83M 55.58M 2.34B

3 months	+3.23%
6 months	-20.99%
Current year	-63.43%